Search research articles
Contact Us
Filters
Showing results (331-340 of 349) with videos related to
Page
of 35
Sort By:
Journal of Medicinal Chemistry
|
January 9, 2025
Phenotype-Led Identification of IL-10 Upregulators in Human CD4<sup>+</sup> T-cells and Elucidation of Their Pharmacology as Highly Selective CDK8/CDK19 Inhibitors
Simon Nicolle, Mike Barker, John Barrett, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 2, 2014
Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers
Sawa Ito, Catherine M Bollard, Mattias Carlsten, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 13, 2005
ABO blood group barrier in allogeneic bone marrow transplantation revisited
Jörg D Seebach, Georg Stussi, Jakob R Passweg, et al.
Science Translational Medicine
|
May 1, 2015
CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo
Patrick J Hanley, Jan J Melenhorst, Sarah Nikiforow, et al.
Blood
|
February 18, 2016
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
Pierre Teira, Minoo Battiwalla, Muthalagu Ramanathan, et al.
Blood Advances
|
March 4, 2022
Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT
Hannah Kinoshita, Kenneth R Cooke, Melanie Grant, et al.
Journal of Medicinal Chemistry
|
September 15, 2018
Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic α
Panayiotis A Procopiou, Niall A Anderson, John Barrett, et al.
Cytotherapy
|
January 3, 2016
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials
Jacques Galipeau, Mauro Krampera, John Barrett, et al.
Blood
|
September 14, 2013
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study
Conrad Russell Y Cruz, Kenneth P Micklethwaite, Barbara Savoldo, et al.
The Lancet. Neurology
|
July 24, 2021
BK virus-specific T cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot study
Irene Cortese, Erin S Beck, Omar Al-Louzi, et al.
Page
of 35
Search research articles
Search
Showing results (331-340 of 349) with videos related to
Sort By:
Page
of 35
Journal of Medicinal Chemistry
|
January 9, 2025
Phenotype-Led Identification of IL-10 Upregulators in Human CD4<sup>+</sup> T-cells and Elucidation of Their Pharmacology as Highly Selective CDK8/CDK19 Inhibitors
Simon Nicolle, Mike Barker, John Barrett, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 2, 2014
Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers
Sawa Ito, Catherine M Bollard, Mattias Carlsten, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 13, 2005
ABO blood group barrier in allogeneic bone marrow transplantation revisited
Jörg D Seebach, Georg Stussi, Jakob R Passweg, et al.
Science Translational Medicine
|
May 1, 2015
CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo
Patrick J Hanley, Jan J Melenhorst, Sarah Nikiforow, et al.
Blood
|
February 18, 2016
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
Pierre Teira, Minoo Battiwalla, Muthalagu Ramanathan, et al.
Blood Advances
|
March 4, 2022
Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT
Hannah Kinoshita, Kenneth R Cooke, Melanie Grant, et al.
Journal of Medicinal Chemistry
|
September 15, 2018
Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic α
Panayiotis A Procopiou, Niall A Anderson, John Barrett, et al.
Cytotherapy
|
January 3, 2016
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials
Jacques Galipeau, Mauro Krampera, John Barrett, et al.
Blood
|
September 14, 2013
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study
Conrad Russell Y Cruz, Kenneth P Micklethwaite, Barbara Savoldo, et al.
The Lancet. Neurology
|
July 24, 2021
BK virus-specific T cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot study
Irene Cortese, Erin S Beck, Omar Al-Louzi, et al.
Page
of 35